FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to ophthalmology, and can be used in treatment of diseases of eye retina. Medication is introduced into vitreal cavity of eye. Laser coagulation of retina is performed. As medication, used is ranibizumbab, which is introduced into lenticular macular canal of vitreous body in dose 0.4 mg. Laser coagulation is performed with power of laser irradiation 100-200 mW, exposure 0.1-0.2 sec, spot diameter 200-300 mcm. Number of coagulants constitutes 250-300.
EFFECT: method makes it possible to reduce trauma and labour-consumption due to preliminary impact of injury focus with preparation suppressing pathologic angiogenesis with further sparing laser impact on retina.
1 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATING AN ILZE'S DISEASE | 2018 |
|
RU2696045C1 |
METHOD FOR MACULAR EDEMA TREATMENT FOR PATIENTS WITH RETINAL VASCULAR DISEASE | 2015 |
|
RU2614105C1 |
METHOD OF TREATMENT OF CHOROIDAL NEOVASCULATION | 2018 |
|
RU2676075C1 |
METHOD FOR PREVENTION OF DIABETIC RETINOPATHY PROGRESSION IN PREGNANT WOMEN WITH DIABETES MELLITUS | 2023 |
|
RU2814772C1 |
METHOD OF TREATING PROLIFERATIVE DIABETIC RETINOPATHY COMPLICATED BY HAEMOPHTHALMIA WITH USING INTRAOPERATIVE FLUORESCEIN ANGIOGRAPHY | 2013 |
|
RU2553510C1 |
METHOD OF PROPHYLAXIS OF DIABETIC RETINOPATHY | 1996 |
|
RU2140235C1 |
METHOD OF TREATING MACULAR OEDEMA ACCOMPANYING RETINOVASCULITIS | 2013 |
|
RU2562022C2 |
METHOD OF LASER TREATMENT OF FUSED DRUSEN IN CASE OF AGE-RELATED MACULAR DEGENERATION | 2011 |
|
RU2472476C1 |
METHOD OF TREATING POSTERIOR UVEITIS | 2013 |
|
RU2546956C2 |
METHOD FOR SURGICAL MANAGEMENT OF CLINICAL OUTCOME OF RETINAL VENOUS THROMBOSIS | 2014 |
|
RU2553388C1 |
Authors
Dates
2012-06-10—Published
2010-12-28—Filed